This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
This scoping review mapped published research on epilepsy of infancy with migrating focal seizures (EIMFS), a rare and severe epilepsy syndrome beginning in infancy.
The provided source contains only publication details for an article in Epilepsia Open.
This hospital-based study looked at 136 children with developmental and epileptic encephalopathies (DEEs).
This study looked at whether computer models built from seizure-free brain recordings could help identify vulnerable parts of the brain network involved in seizure onset during presurgical evaluation for drug-resistant epilepsy.
This report describes one child: a 12-year-old girl who presented at age 11 with daily absence seizures that did not respond to multiple antiseizure medicines.
This study examined how intellectual test scores changed over time in children and adolescents who had brain surgery for pharmacoresistant epilepsy.
This study looked at thalamic neuromodulation for children with drug-resistant epilepsy, meaning epilepsy that did not respond well to medicines.
This study looked at whether brain PET scan templates made for children, and matched to different ages, can help improve localization of the epileptogenic zone, the brain area where seizures start, in children with drug-resistant epilepsy.
This paper is a review, not a new experiment.